BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28776955)

  • 1. Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.
    Jang S; Jin H; Roy M; Ma AL; Gong S; Jaskula-Sztul R; Chen H
    Cancer Med; 2017 Sep; 6(9):2142-2152. PubMed ID: 28776955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
    Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
    J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth
    Jang S; Janssen A; Aburjania Z; Robers MB; Harrison A; Dammalapati A; Cheng YQ; Chen H; Jaskula-Sztul R
    Oncotarget; 2017 Sep; 8(41):70828-70840. PubMed ID: 29050323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.
    Mohammed TA; Holen KD; Jaskula-Sztul R; Mulkerin D; Lubner SJ; Schelman WR; Eickhoff J; Chen H; Loconte NK
    Oncologist; 2011; 16(6):835-43. PubMed ID: 21632454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor.
    Hsieh YJ; Hwu L; Chen YC; Ke CC; Chen FD; Wang HE; Lin KP; Yeh HH; Chang CW; Liu RS
    J Nucl Med; 2014 Apr; 55(4):678-85. PubMed ID: 24639460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
    Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
    Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
    Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
    Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.
    Wawruszak A; Luszczki JJ; Kalafut J; Okla K; Halasa M; Rivero-Muller A; Stepulak A
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together.
    Wawruszak A; Luszczki J; Halasa M; Okon E; Landor S; Sahlgren C; Rivero-Muller A; Stepulak A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
    Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
    Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism.
    Yao J; Qian CJ; Ye B; Zhang X; Liang Y
    Life Sci; 2012 Sep; 91(5-6):186-93. PubMed ID: 22781708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.
    Wilson AJ; Chueh AC; Tögel L; Corner GA; Ahmed N; Goel S; Byun DS; Nasser S; Houston MA; Jhawer M; Smartt HJ; Murray LB; Nicholas C; Heerdt BG; Arango D; Augenlicht LH; Mariadason JM
    Cancer Res; 2010 Jan; 70(2):609-20. PubMed ID: 20068171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay.
    Grabiec AM; Korchynskyi O; Tak PP; Reedquist KA
    Ann Rheum Dis; 2012 Mar; 71(3):424-31. PubMed ID: 21953341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
    Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
    Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone modifications of Notch1 promoter affect lung CD4+ T cell differentiation in asthmatic rats.
    Cui ZL; Gu W; Ding T; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
    Int J Immunopathol Pharmacol; 2013; 26(2):371-81. PubMed ID: 23755752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
    Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
    Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors.
    Jordaan G; Liao W; Sharma S
    BMC Cancer; 2013 Feb; 13():88. PubMed ID: 23432814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
    Chikamatsu K; Ishii H; Murata T; Sakakura K; Shino M; Toyoda M; Takahashi K; Masuyama K
    Cancer Sci; 2013 Nov; 104(11):1468-75. PubMed ID: 23992541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.